North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)
The North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is expected to reach US$ 2,719.4 million by 2028 from US$ 1,204.4 million in 2021; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028.
The poll conducted by Pew Research Center stated that 52% of the US adults do not favor animal use in scientific research. Additionally, other surveys found rest of the population accept animal experimentation is because they believe it to be necessary for medical research growth. Thus, the growing concerns related to the harm caused to animals during different clinical trials have created a demand for alternative methods for carrying out these trials, such as in-silico trials. In-silico clinical trials have overcome the disadvantages of animal testing and are considered a better method due to high accuracy, low cost, and time efficiency. In-silico clinical trials offer an effective way of replacing animal anatomies for conducting various experiments and research & development activities, thus, supporting the growth of the in-silico trials market during the forecast period. Additionally, rapidly increasing concerns over animal welfare and consistent efforts of human and animal rights and welfare organizations are boosting the growth of the North America in-silico trials market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market at a promising CAGR during the forecast period.
North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
The North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented on the basis of organization size, offerings, application, clinical indication, and end user. Based on organization size, the market is bifurcated into small and medium organizations and large organizations. Based on offerings, the North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into products, platforms, and services. Based on application, the market is segmented into product design and discovery, product development, pre-clinical targeting, assessment of drugs and other biomedical products, and others. Based on clinical indication, the market is segmented into cardiovascular diseases, neurodegenerative diseases, oncology, rare diseases, metabolic diseases, immune based diseases, infectious diseases, and others. Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, medical technology companies, contract research organizations, and others. By country, the North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into the US, Canada, and Mexico.
InSilicoTrials Technologies; Dassault Systèmes SE; Certara Inc.; Computational Life; NOVA; Ansys, Inc.; Synopsys, Inc.; Sensyne Health plc.; Phesi; Tempus; and Cerner Corporation are among the leading companies in the North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.2.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Organization Size
1.2.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Offering
1.2.3 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Application
1.2.4 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Clinical Indication
1.2.5 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By End User
1.2.6 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. In-Silico Trial Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Concerns Over Animal Welfare and Benefits
5.1.2 Insufficient Variable Patient Data and Limited Timescale
5.2 Market Restraints
5.2.1 Insufficient Variable Patient Data and Limited Timescale
5.3 Market Opportunities
5.3.1 Growing Applications of In-silico Trials in Radiology and Orthopedic Device Industry
5.4 Future Trends
5.4.1 Adoption of Artificial Intelligence in In-Silico Drug Discovery
5.5 Impact Analysis
6. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– North America Analysis
6.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue Forecast and Analysis
7. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028– by Organization Size
7.1 Overview
7.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, By Organization Size, 2020 & 2028 (%)
7.3 Large Organizations
7.3.1 Overview
7.3.2 Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Small and Medium Organizations
7.4.1 Overview
7.4.2 Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
8. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Offering
8.1 Overview
8.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
8.3 Products
8.3.1 Overview
8.3.2 Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
8.4 Platforms
8.4.1 Overview
8.4.2 Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Application
9.1 Overview
9.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
9.3 Product Design and Discovery
9.3.1 Overview
9.3.2 Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.4 Product Development
9.4.1 Overview
9.4.2 Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.5 Pre-Clinical Targeting
9.5.1 Overview
9.5.2 Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.6 Assessment of Drugs and Other Biomedical Products
9.6.1 Overview
9.6.2 Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others (Optimization and Market Access)
9.7.1 Overview
9.7.2 Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Clinical Indication
10.1 Overview
10.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
10.3 Cardiovascular Disease
10.3.1 Overview
10.3.2 Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.4 Neurodegenerative Disease
10.4.1 Overview
10.4.2 Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.5 Oncology
10.5.1 Overview
10.5.2 Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.6 Rare Diseases
10.6.1 Overview
10.6.2 Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.7 Metabolic Diseases
10.7.1 Overview
10.7.2 Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.8 Immune Based Diseases
10.8.1 Overview
10.8.2 Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.9 Infectious Diseases
10.9.1 Overview
10.9.2 Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
10.10 Others (Haematology, Diabetes, Dermatology)
10.10.1 Overview
10.10.2 Others (Haematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – End User
11.1 Overview
11.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.4 Medical Technology Companies
11.4.1 Overview
11.4.2 Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
11.6 Others (Universities and Research Centres)
11.6.1 Overview
11.6.2 Others (Universities and Research Centres): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
12. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
12.1.1 Overview
12.1.2 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)
12.1.4 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)
12.1.5 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)
12.1.6 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)
12.1.7 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)
12.1.8 North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)
12.1.8.1 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)
12.1.8.1.4 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)
12.1.8.1.5 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)
12.1.8.1.6 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)
12.1.8.1.7 US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)
12.1.8.2 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)
12.1.8.2.4 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)
12.1.8.2.5 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)
12.1.8.2.6 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)
12.1.8.2.7 Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)
12.1.8.3 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)
12.1.8.3.4 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)
12.1.8.3.5 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)
12.1.8.3.6 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)
12.1.8.3.7 Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)
13. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 InSilicoTrials Technologies
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Dassault Systèmes SE
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Certara Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Computational Life
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Ansys, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Synopsys, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Sensyne Health plc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Phesi
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Tempus
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Cerner Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (USD Million)
Table 3. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 4. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
Table 6. US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 7. US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 8. US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Organic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Table 22. Inorganic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Table 23. Glossary of Terms
LIST OF FIGURES
Figure 1. In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation
Figure 2. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview
Figure 3. Large Organizations Segment Held Largest Share of Organization Size Segment in In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Figure 4. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, Industry Landscape
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. In-Silico Trial Market: Impact Analysis of Drivers and Restraints
Figure 9. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2020 & 2028 (%)
Figure 11. Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 14. Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 15. Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 16. Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 18. Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 24. Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Others (Hematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)
Figure 33. Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Others (Universities and Research Centers): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Key Country – Revenue (2021) (US$ Million)
Figure 38. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)
Figure 40. US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)
- InSilicoTrials Technologies
- Dassault Systèmes SE
- Certara Inc.
- Computational Life
- Ansys, Inc.
- Synopsys, Inc.
- Sensyne Health plc.
- Phesi
- Tempus
- Cerner Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.